Display options
Cite
Queiroz CJ, Nakata CM, Solito E, et al. Relationship between HPV and the biomarkers annexin A1 and p53 in oropharyngeal cancer. Infect Agent Cancer. 2014;9:13doi: 10.1186/1750-9378-9-13.
Queiroz, C. J., Nakata, C. M., Solito, E., & Damazo, A. S. (2014). Relationship between HPV and the biomarkers annexin A1 and p53 in oropharyngeal cancer. Infectious agents and cancer, 913. https://doi.org/10.1186/1750-9378-9-13
Queiroz, Cleberson Jean Dos Santos, et al. "Relationship between HPV and the biomarkers annexin A1 and p53 in oropharyngeal cancer." Infectious agents and cancer vol. 9 (2014): 13. doi: https://doi.org/10.1186/1750-9378-9-13
Queiroz CJ, Nakata CM, Solito E, Damazo AS. Relationship between HPV and the biomarkers annexin A1 and p53 in oropharyngeal cancer. Infect Agent Cancer. 2014 Apr 21;9:13. doi: 10.1186/1750-9378-9-13. eCollection 2014. PMID: 24782913; PMCID: PMC4003510.
Copy Download .nbib Format: NLM
Share it on

Infect Agent Cancer. 2014 Apr 21;9:13. doi: 10.1186/1750-9378-9-13. eCollection 2014.

Relationship between HPV and the biomarkers annexin A1 and p53 in oropharyngeal cancer.

Infectious agents and cancer

Cleberson Jean Dos Santos Queiroz, Cíntia Mara de Amorim Gomes Nakata, Egle Solito, Amílcar Sabino Damazo

Affiliations

  1. Post-Graduation in Health Science, Faculty of Medicine (FM), Federal University of Mato Grosso (UFMT), Mato Grosso, MT 78060-900, Brazil ; Department of Gastroenterology, Institute of Translational Medicine, University of Liverpool, Liverpool L69 3GE, UK ; Henry Wellcome Laboratory, University of Liverpool, 1st Floor, Nuffield Building, Liverpool L69 3GE, UK.
  2. Post-Graduation in Health Science, Faculty of Medicine (FM), Federal University of Mato Grosso (UFMT), Mato Grosso, MT 78060-900, Brazil.
  3. William Harvey Research Institute; Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.
  4. Post-Graduation in Health Science, Faculty of Medicine (FM), Federal University of Mato Grosso (UFMT), Mato Grosso, MT 78060-900, Brazil ; Department of Basic Science in Health; Faculty of Medicine (FM), Federal University of Mato Grosso (UFMT), Mato Grosso, MT 78060-900, Brazil.

PMID: 24782913 PMCID: PMC4003510 DOI: 10.1186/1750-9378-9-13

Abstract

BACKGROUND: Human papillomavirus (HPV) is often present in oropharyngeal cancers. Head and neck tumors have been examined for other molecular markers including p53 and annexin A1 (ANXA1). Here, we investigated the prevalence of HPV and its relationship with p53 and ANXA1 in patients with oropharyngeal cancer.

METHODS: We have analyzed tumor and adjacent mucosa from 22 patients with squamous cell carcinoma of the oropharynx in addition to samples of the oropharyngeal epithelium in subjects without cancer. We evaluated the presence of the HPV (subtypes 16/18 and 31/33) by chromogenic in situ hybridization. Additionally, we used immunofluorescence to examine the expression of p16, p53, ANXA1 and the phosphorylation of the ANXA1 residues Ser27 (ANXA1-SER) and Tyr21 (ANXA1-TYR).

RESULTS: We have detected the presence of HPV genome in 59% of the 22 tumors. Of those, 92% were also positive for p16 immunostaining. Furthermore, we demonstrated a reduction in the expression of p53 in HPV + compared to HPV- tumors. Also, a reduction was observed in the expression of ANXA1 in tumors compared to epithelium from the margins and from controls. We also noted a reduction in ANXA1-TYR in tumors. However, the expression of both ANXA1 and ANXA1-SER were elevated in the margins of the HPV + versus HPV- tumors.

CONCLUSIONS: Our results confirm a high prevalence of HPV in oropharyngeal cancer and a reduction in p53 expression in HPV + tumors. We observed a hypoexpression of ANXA1 and ANXA1-TYR in oropharyngeal cancer. The increase in ANXA1-SER in the margins of HPV + tumors suggests that the epithelium in these cases had been activated by an infectious agent. Those findings indicate that ANXA1 and its phosphorylated forms can play important roles in the response to HPV infection and the carcinogenesis of the oropharynx.

Keywords: Annexin A1; Cancer; HPV; Oropharynx; p53

References

  1. Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):467-75 - PubMed
  2. J Cell Biochem. 2009 Apr 15;106(6):1123-35 - PubMed
  3. Cell Mol Life Sci. 1997 Jun;53(6):522-6 - PubMed
  4. FASEB J. 2003 Aug;17(11):1544-6 - PubMed
  5. Am J Rhinol. 2005 Sep-Oct;19(5):483-7 - PubMed
  6. Science. 1990 Aug 24;249(4971):912-5 - PubMed
  7. Oncogene. 1998 Oct 15;17(15):1923-30 - PubMed
  8. Eur J Cancer Prev. 2009 Apr;18(2):120-6 - PubMed
  9. Mod Pathol. 2008 Apr;21(4):376-86 - PubMed
  10. Nat Rev Cancer. 2009 Oct;9(10):749-58 - PubMed
  11. Int J Cancer. 2003 Nov 10;107(3):394-400 - PubMed
  12. Mol Cell Biol. 1990 Nov;10(11):5772-81 - PubMed
  13. Clin Cancer Res. 2008 Jan 15;14(2):435-45 - PubMed
  14. Otolaryngol Head Neck Surg. 1998 Jan;118(1):115-23 - PubMed
  15. Clin Cancer Res. 2008 Jan 15;14(2):366-9 - PubMed
  16. J Carcinog. 2008 Jul 17;7:2 - PubMed
  17. Neoplasma. 2010;57(3):253-9 - PubMed
  18. Proc Natl Acad Sci U S A. 1992 May 15;89(10):4495-9 - PubMed
  19. Clin Exp Metastasis. 1997 Mar;15(2):151-6 - PubMed
  20. J Clin Oncol. 2013 Feb 10;31(5):543-50 - PubMed
  21. Hum Pathol. 1989 Aug;20(8):772-6 - PubMed
  22. Lancet. 1991 Aug 24;338(8765):513 - PubMed
  23. J Clin Virol. 2005 Mar;32 Suppl 1:S7-15 - PubMed
  24. J Biol Chem. 1999 Dec 31;274(53):37620-8 - PubMed
  25. Oncogene. 1997 Oct 16;15(16):1889-93 - PubMed
  26. J Oral Pathol Med. 2009 Apr;38(4):362-70 - PubMed
  27. Int J Cancer. 2010 Dec 15;127(12):2893-917 - PubMed
  28. J Immunol. 2006 Apr 1;176(7):4410-8 - PubMed
  29. Nature. 1991 Jul 25;352(6333):345-7 - PubMed
  30. N Engl J Med. 2010 Jul 1;363(1):24-35 - PubMed
  31. Histopathology. 2008 Dec;53(6):715-27 - PubMed
  32. J Clin Oncol. 2008 Jul 1;26(19):3128-37 - PubMed
  33. Clin Cancer Res. 2006 Aug 1;12(15):4598-604 - PubMed
  34. Clin Cancer Res. 2002 Jan;8(1):117-23 - PubMed
  35. Oral Oncol. 2009 Jun;45(6):486-91 - PubMed
  36. Hepatology. 2000 Feb;31(2):371-80 - PubMed
  37. Endocrinology. 2003 Apr;144(4):1164-74 - PubMed
  38. Nature. 1979 Mar 29;278(5703):456-9 - PubMed
  39. Head Neck. 2010 Jul;32(7):946-58 - PubMed
  40. J Exp Med. 2011 Sep 26;208(10):1937-40 - PubMed
  41. FEBS Lett. 2004 Dec 3;578(1-2):95-8 - PubMed
  42. World J Gastroenterol. 2004 May 15;10(10):1466-70 - PubMed
  43. Am J Pathol. 2004 Jan;164(1):73-9 - PubMed
  44. Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3571-5 - PubMed
  45. Int J Cancer. 2014 Feb 1;134(3):497-507 - PubMed
  46. Traffic. 2007 Aug;8(8):951-8 - PubMed
  47. Inflamm Res. 2008 Mar;57(3):97-103 - PubMed
  48. Biochemistry. 1992 Oct 20;31(41):9934-9 - PubMed
  49. PLoS One. 2013;8(1):e53260 - PubMed
  50. Clin Exp Metastasis. 2008;25(7):695-702 - PubMed
  51. Nature. 2007 Feb 8;445(7128):656-60 - PubMed
  52. Cancer Res. 1988 Jun 1;48(11):3282-7 - PubMed
  53. Hepatology. 1996 Jul;24(1):72-81 - PubMed
  54. Mol Cell Biol. 2008 Aug;28(15):4665-74 - PubMed
  55. FASEB J. 2006 Jul;20(9):1498-500 - PubMed
  56. Ital J Anat Embryol. 2001;106(2 Suppl 1):69-77 - PubMed
  57. Physiol Rev. 2002 Apr;82(2):331-71 - PubMed

Publication Types